You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

September 16, 2025

Kratom: Business Compliance Roadmap for Thailand

Since Thailand formally removed Mitragyna speciosa (kratom) from the list of narcotic drugs, the country has progressed from outright prohibition to a structured, license-based regime. While the Ministry of Public Health oversees cannabis plant regulation, the Ministry of Justice (MOJ) is the regulatory authority overseeing kratom plants. For the avoidance of doubt, separate Ministry of Public Health notifications prohibit the use of kratom as a food ingredient unless a food safety evaluation has been conducted; however, this restriction does not affect trade in unprocessed leaves per se.

For businesses in Thailand dealing exclusively in kratom leaves, the most consequential development is the Ministerial Regulation on the Application for Permits and Notifications for the Importation and Exportation of Kratom Leaves B.E. 2568 (2025), a bylaw of the Kratom Plant Act 2022. The ministerial regulation establishes the following notable definitions:

  • “Kratom leaves”: Fresh or dried leaves in their natural, unprocessed state (no extracts, concentrates, or infused products).
  • “Import/Export”: Any act of bringing kratom leaves into or out of Thailand, whether for commercial sale, industrial processing abroad, or research.

Import/Export Licensing

Under the Kratom Plant Act, a license is mandatory for importing or exporting kratom leaves. Individuals, juristic persons, community enterprises, and state agencies in Thailand are eligible to obtain a license to import (or a license to export) kratom leaves. Licenses are available to qualified individuals and juristic persons.

Individuals must satisfy the following qualifications to be eligible for a license:

  • Thai nationality, ≥ 20 years old, resident in Thailand.
  • Not incompetent, quasi-incompetent, or under legal guardianship.
  • No license suspension currently in force under the Kratom Act or Narcotics Code.
  • No license revocation in the previous two years.
  • No conviction under the Kratom Act or Narcotics Code within the previous two years (unless fully released from punishment).

Juristic persons must satisfy the following qualifications to be eligible for a license:

  • Structured as a company or a limited partnership corporation in Thailand.
  • Thai nationals composing two-thirds of the business directors or partners/shareholders.
  • A registered office located in Thailand.
  • The company and its authorized representatives satisfy the same “clean slate” criteria as individuals.

Applicants must file official MOJ forms—available through the Narcotics Control Board’s e-licensing portal—with the core attachments listed below.

  • Identity documentation:
    • Individuals: Thai national ID; house registration.
    • Companies: Certificate of Incorporation (issued within the previous six months); list of directors/shareholders; company seal specimen.
  • Map or floor plan of the premises clearly identifying storage areas for kratom leaves to be imported/exported.
  • Import/export forecast (covering 12 months) detailing:
    • Projected volumes per quarter.
    • Source country/destination country.
    • Intended end-use (e.g., wholesale resale, research supply, etc.).
  • Purpose statement explaining how the activity aligns with the Kratom Plant Act (e.g., for commercial trade, R&D supply chain, etc.).

The license application must be filed via the website of the Office of the Narcotics Control Board (ONCB). The cost is THB 5,000 per application under the current ministerial fee schedule. Application evaluation will be completed within 30 business days. The license will be valid for five (5) calendar years from issuance.

In addition to being licensed to import/export kratom leaves, pre-shipment notification through the National Single Window system of the ONCB is also required. This means that even after securing a five-year license, each shipment must be precleared. A notification form must be submitted to the ONCB at least seven business days before the intended import/export date. The notification must include quantity, lot numbers (if any), port of entry/exit, flight or vessel details, and so on. Following the submission of the notification via the NSW system, within three business days, the ONCB will issue a “notification receipt code,” which customs officers will use to validate the clearance process. Failure to lodge a shipment notice constitutes a separate offense, punishable by an administrative fine and potential license suspension.

Compliance Outlook

Through the 2025 ministerial regulation now in force, Thailand offers a clear, predictable route for lawful cross-border trade in kratom leaves. While the licensing process is rigorous, the five-year validity period and electronic filing system create operational certainty for compliant traders. Business operators in Thailand should understand the legal and procedural requirements and ensure that staff are trained to leverage these opportunities and avoid the significant penalties attached to noncompliance.

RELATED INSIGHTS​ 

July 4, 2023
Practitioners from Tilleke & Gibbins’ Vietnam offices contributed content for the latest edition of the Practical Law Life Sciences Global Guide. The guide provides a comparative overview, in Q&A format, of laws and regulations on pharmaceuticals, medical devices, and other life sciences products in dozens of jurisdictions around the world. The Life Sciences Global Guide is divided into two sections: Commercialization (see more details here) and Regulation, which covers the following topics: Pharmaceuticals: Laws and regulatory authorities Clinical trials: Legal, regulatory, and procedural requirements Manufacturing and distribution Marketing: Authorization for marketing medicinal products, monitoring compliance and penalties, pharmacovigilance and other commitments, foreign marketing authorizations Data privacy Packaging, labeling, and tracking Biological medicines Medical devices: Legislation and regulatory authorities, definition and classification Healthcare IT Combination products and borderlines Natural health products Recent developments and reform proposals Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. The full “Life Sciences Regulation in Vietnam” section can be found on the Practical Law website.
June 1, 2023
Life sciences specialists from Tilleke & Gibbins have supplied the Thailand and Vietnam contributions to the International Bar Association (IBA) Healthcare and Life Sciences Law Committee’s global telemedicine survey. The survey, spanning 54 jurisdictions worldwide, functions as a comparative legal guide on the provision of telemedicine and related products and services. It offers practitioners and industry users access to relevant rules and regulations, addressing key aspects such as regulation, data privacy, liability, and recent developments in telemedicine. Telemedicine has emerged as a transformative force in healthcare, revolutionizing the way medical services are accessed and delivered. As in many other jurisdictions, telemedicine has gained prevalence in Thailand and Vietnam, as it enables patients to remotely consult with healthcare professionals, access diagnostic services, and receive timely medical advice while minimizing physical contact. As the global healthcare landscape continues to evolve, understanding the legal and regulatory aspects of telemedicine becomes paramount, making initiatives like the IBA’s telemedicine survey vital for practitioners and industry stakeholders. The IBA is a globally recognized organization that brings together legal professionals and bar associations from around the world, and its Healthcare and Life Sciences Law Committee plays a crucial role in addressing legal issues and developments in the healthcare industry. The complete surveys for Thailand and Vietnam­—and the 52 other participating jurisdictions—are available on the IBA website.
May 23, 2023
Life sciences specialists at Tilleke & Gibbins’ office in Bangkok have contributed a new “Life Sciences Commercialization in Thailand” chapter to the Life Sciences Global Guide from Practical Law. The Q&A-style guide provides strategic information for companies active in the life sciences sector in Thailand. The chapter covers a number of key areas: Overview of the life sciences sector Pricing, government funding, and reimbursement: National health care system, price regulation and reimbursement Distribution and sale Cross-border trade and parallel imports Advertising and engagement with patient organizations Patents: Conditions for patentability, registration, length of protection, infringement, international treaties Trademarks: Requirements, registration Competition law issues: Authorities and legislation, commercial contracts and competition law, licensing approvals and formalities Product liability: Regulators, medicinal product liability law, liable partners, defenses, product liability claims, remedies Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. The full “Life Sciences Commercialization in Thailand” section can be found on the Practical Law website.
May 23, 2023
The latest update to Practical Law’s Life Sciences Global Guide includes a new “Life Sciences Regulation in Thailand” chapter by attorneys in Tilleke & Gibbins’ Bangkok office. The chapter covers a range of regulatory issues related to development, manufacturing, and selling of pharmaceutical products and medical devices in Thailand. The chapter provides important information on the following topics: Pharmaceuticals: Laws and regulatory authorities Clinical trials: Legal, regulatory, and procedural requirements Manufacturing and distribution Marketing: Authorization for marketing medicinal products, monitoring compliance and penalties, pharmacovigilance and other commitments, foreign marketing authorizations Data privacy Packaging, labeling, and tracking Biological medicines Medical devices: Legislation and regulatory authorities, definition and classification Healthcare IT Combination products and borderlines Natural health products Developments, reforms, and proposals Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. The full “Life Sciences Regulation in Thailand” chapter can be accessed on the Practical Law website.